Content-Length: 56029 | pFad | https://app.mc.uky.edu/mcctrials/cancer/sarcoma
Protocol No. | Title |
---|---|
MCC-16-MULTI-18-PMC | Genomic Testing for Patients with Refractory Cancer to Determine Treatment |
MCC-16-MULTI-19-PMC | Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies |
MCC-17-MTB-01-PMC | MCC-17-MTB-01-PMC: Total Cancer Care Protocol: A Lifetime Partnership with Patients Who Have or May be at Risk of Having Cancer |
NCI-CIRB-ACNS1831 | ACNS1831-Selumetinib v CV in ND NF-1 Associated LGG |
NCI-CIRB-APEC14B1 | Project:EveryChild |
NCI-CIRB-APEC1621-SC | Pediatric MATCH - Screening Protocol |
NMTRC014 | Difluoromethylornithine for Neuroblastoma Maintenance Therapy |
Protocol No. | Title |
---|---|
MCC-16-MULTI-18-PMC | Genomic Testing for Patients with Refractory Cancer to Determine Treatment |
MCC-16-MULTI-19-PMC | Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies |
MCC-17-MTB-01-PMC | MCC-17-MTB-01-PMC: Total Cancer Care Protocol: A Lifetime Partnership with Patients Who Have or May be at Risk of Having Cancer |
NCI-CIRB-ACNS1831 | ACNS1831-Selumetinib v CV in ND NF-1 Associated LGG |
NCI-CIRB-APEC14B1 | Project:EveryChild |
NCI-CIRB-APEC1621-SC | Pediatric MATCH - Screening Protocol |
NMTRC014 | Difluoromethylornithine for Neuroblastoma Maintenance Therapy |
Protocol No. | Title |
---|---|
NCI-CIRB-ACNS1831 | ACNS1831-Selumetinib v CV in ND NF-1 Associated LGG |
NCI-CIRB-APEC14B1 | Project:EveryChild |
NCI-CIRB-APEC1621-SC | Pediatric MATCH - Screening Protocol |
NMTRC014 | Difluoromethylornithine for Neuroblastoma Maintenance Therapy |
Fetched URL: https://app.mc.uky.edu/mcctrials/cancer/sarcoma
Alternative Proxies: